Sonsire Fernández-Castillo

SARS-CoV-2 RBD-Tetanus Toxoid Conjugate Vaccine Induces a Strong Neutralizing Immunity in Preclinical Studies

Yury Valdés-Balbín, Darielys Santana-Mederos, Lauren Quintero et al. · ACS Chemical Biology · 2021 · 88 citations · Full text

Vaccination, Vaccine Development, Virus Infection +13

Safety and efficacy of the two doses conjugated protein-based SOBERANA-02 COVID-19 vaccine and of a heterologous three-dose combination with SOBERANA-Plus: a double-blind, randomised, placebo-controlled phase 3 clinical trial

María Eugenia Toledo-Romaní, Mayra García-Carmenate, Carmen Valenzuela‐Silva et al. · The Lancet Regional Health - Americas · 2022 · 44 citations · Full text

A new oral vaccine candidate based on the microencapsulation by spray-drying of inactivated Vibrio cholerae

Gemma Año, Amaia Esquisabel, Marta Pastor et al. · Vaccine · 2011 · 43 citations

Vaccination, Mucosal Vaccination, Vaccine Development +6

Safety and immunogenicity of anti-SARS CoV-2 vaccine SOBERANA 02 in homologous or heterologous scheme: Open label phase I and phase IIa clinical trials

María Eugenia-Toledo-Romaní, Leslyhana Verdecia-Sánchez, Meiby Rodríguez-González et al. · Vaccine · 2022 · 38 citations · Full text

Vaccination, Vaccine Safety, Open Label Phase +6

Proteoliposomes from Mycobacterium smegmatis induce immune cross-reactivity against Mycobacterium tuberculosis antigens in mice

Lissete Rodriguez, Yanelys Tirado, Fátima Reyes et al. · Vaccine · 2011 · 34 citations

Inflammation, Pulmonary Tuberculosis, Autoimmune Disease +8